SI-BONE presents a new implant system for the Becken fractures for Von Investing.com

SANTA CLARA, California – SI-BONE, Inc. (NASDAQ: SIBN), a medical device specialist for cost management, is making first inroads with its new eingeführten iFuse TORQ TNT™ implant system. The device, which is the first in the US, has 3D printed transiliac-transsacral Schraube, which improves the surgical experience in patients with Becken fractures.

With iFuse TORQ TNT™, since August 2024, the FDA 510(k) guidance has been implemented and ended up as a lifespan extension, allowing the restriction to be adjusted according to the air wind. Das Design arose from an initial fixation and the reduction of complications with schraubenlockerung, which is in patients with good quality of care.

The first operations with the new system are performed by renowned surgeons in the various country clinics, where Dr. Edward Westrick at Allegheny General Hospital in Pittsburgh and Dr. Reza Firoozabadi at Harborview Medical Center in Seattle. The surgical reports of positive experiences and the efficiency of implant systems provide the potential for rapid patient generation.

Dr. J.D. Black of Kadlec Regional Medical Center in Richland performed efficient implant design, an implant and surgery procedure. Dr. Brian Cunningham of the Methodist Hospital – HealthPartners in St. Louis Park has adopted the 3D treatment in the treatment of osseointegration, because there is a lot of experience in the long-term healing of patients with osteoporosis.

Laura Francis, CEO of SI-BONE, has taken the next steps and positioned the iFuse TORQ TNT™ as a fortifier in treatment-complex Becken fractures. The medical position of the patient in surgical surgical examination is carried out by a medical clinical evidence, an amount of 100,000 during an operation of more than 3,900 surgeons.

SI-BONE’s portfolio offers minimally invasive surgical procedures for iliosacral joints and ultra-rapid deformities for erectile dysfunction, spinopelvin fixation and pelvic trauma. There is a good chance that the new implant system will make a different start to SI-BONE’s market position.

In other cases, SI-BONE Inc. reports. for the quarter quarter 2024 a well-deserved gain of 20% on a record of 40 million US dollars, which gains a higher value on the US market. The outlook for 2024 global sales at $165 million and $167 million was a 19% to 20% wait ahead.

Analysts from Piper Sandler and Canaccord Genuity have provided positive research on SI-BONE, which has proven the strong growth and potential of TORQ TNT-Systems. SI-BONE factory produces new products for the Beckenmarkt and aims to reach a volume of US$200 million by the end of 2024.

InvestingPro Acknowledgment

Laut InvestingPro-Daten have staked SI-BONE’s market capitalization at US$535.35 million. The second installment will be played on the beach in the last month of 2024 from 21.15% to 150.71 million US dollars. These waiting lists are in a long time with the correct product infusion and care for the surgical procedure.

The positive interest rate is not profitable, with a negative effect of US$45.8 million in the last month of the month. Furthermore, financial flexibility for more investments was possible.

The best performance of the active war with a 1 month trend of -18.11% reausordernd. This fleeting flight can increase the opportunity for investors, increasing the long-term potential of the onternehmens, without creating a problem with the iFuse TORQ TNT™ systems.

For a more comprehensive analysis, InvestingPro offers a combination of knowledge with 7 new painting tips for SI-BONE, which offers a variety of financial positions and market-oriented markets.

This description can be performed by the intelligent intelligence. Weitere Informationen entnehmen Sie bitte unseren Nutzungsbedingungen.